Viemed Healthcare, Inc. Financial Ratios — VMD Stock

Profitability (USD)

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	48.18	39.42	26.37	56.15	11.25	7.22	11.18	10.66	12.83
Return on Assets (%)	- -	26.22	20.82	12.51	32.31	7.92	5.3	7.53	6.79	7.94
Return on Capital (%)	- -	37.05	34.08	20.16	- -	10.41	7.08	10.86	10.13	11.81
Return on Invested Capital (%)	- -	65.89	34.59	20.44	- -	9.84	6.48	10.42	8.7	9.64
Gross Margin (%)	60.14	73.76	74.11	69.78	61.01	62.71	60.99	61.63	59.4	57.52
EBITDA Margin (%)	19.72	35.18	21.66	19.46	25.92	19.94	17.45	20.13	18.44	18.25
Operating Margin (%)	15.17	29.76	15.79	11.48	18.62	10.27	6.19	8.18	7.13	7.66
Incremental Operating Margin (%)	- -	59.13	-21.58	-6.1	29.84	87.21	-15.76	14.44	2.47	10.24
Pretax Margin (%)	0.35	17.45	15	10.96	20.08	10.68	6.48	7.86	7.21	8.05
Profit Margin (%)	3.92	17.42	14.75	10.62	24.01	7.8	4.48	5.6	5.02	5.53
Net Income to Common Margin (%)	3.92	17.42	14.75	10.62	24.01	7.8	4.48	5.6	5.02	5.53
Effective Tax Rate (%)	- -	0.18	1.68	3.08	- -	27.01	30.79	28.82	29.44	29.36
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	48.18	39.42	26.37	56.15	11.25	7.22	11.18	10.66	12.83

Credit (USD)

API Chat

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	6	5	3	20	11	7	1	10	7	16
ST Debt	4	4	3	9	5	2	- -	2	1	2
LT Debt	3	1	- -	11	7	5	- -	8	6	14
Total Debt/EBITDA	1.05	0.31	0.25	1.25	0.33	0.28	0.03	0.28	0.17	0.32
Net Debt/EBITDA	-0.63	-0.31	-0.75	-0.25	-0.69	-0.97	-0.7	-0.16	-0.33	-0.02
Total Debt/EBIT	1.36	0.37	0.34	2.12	0.46	0.54	0.08	0.69	0.43	0.77
Net Debt/EBIT	-0.82	-0.37	-1.02	-0.43	-0.95	-1.88	-1.97	-0.38	-0.85	-0.05
EBITDA to Interest Expense	19.14	60.69	77.15	49.74	66.87	73.4	122.98	86.88	53.3	41.73
EBITDA-CapEx/Interest Expense	13.96	45.98	43.37	7.11	41.24	11.31	6.75	25.34	4.63	7.9
EBIT to Interest Expense	14.73	51.35	56.25	29.35	48.04	37.82	43.64	35.32	20.61	17.52
Interest Expense	- -	- -	- -	- -	1	- -	- -	- -	1	1
Common Equity/Total Assets	52.19	55.86	50.66	45.38	66.47	74.05	72.6	63.4	63.85	60.16
Long-Term Debt/Equity (%)	20.43	3.36	1.21	24.41	8.03	4.82	0.2	7.3	4.2	9.51
Long-Term Debt/Capital (%)	13.58	3.04	1.29	18.72	7.63	4.87	0.23	7.66	4.59	9.91
Long-Term Debt/Total Assets (%)	10.66	2.12	0.73	12.92	5.83	3.88	0.17	5.37	3.16	6.86
Total Debt/Equity (%)	50.39	21.81	10.52	44.65	13.63	6.87	0.71	9.06	5.15	11.11
Total Debt/Capital (%)	33.51	19.74	11.19	34.24	12.95	6.94	0.81	9.51	5.64	11.58
Total Debt/Total Assets (%)	26.3	13.74	6.38	23.62	9.89	5.53	0.59	6.67	3.88	8.01
Net Debt to Equity	-30.13	-21.47	-31.97	-9.1	-28.58	-23.86	-17.42	-5.06	-10.16	-0.78
Net Debt/Capital (%)	-25.82	-24.12	-51.57	-9.11	-42.47	-34.56	-24.6	-6.03	-12.98	-0.9
EBITDA	6	17	14	16	34	23	24	37	41	49
EBITDA-CapEx	5	13	8	2	21	4	1	11	4	9
Operating Income (Loss)	5	14	10	9	24	12	9	15	16	21

Liquidity (USD)

API Chat

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	0.47	0.39	0.53	0.52	1.35	1.59	0.9	0.4	0.47	0.33
Current Ratio	1.22	1.29	1.18	1.07	2.05	2.66	2.11	1.19	1.42	1.18
Quick Ratio	1	1.13	0.98	0.96	1.88	2.42	1.71	0.97	1.14	0.96
CFO/Avg Current Liab	- -	1.08	1.37	0.84	1.44	1.1	1.51	1.77	1.13	1.32
Common Equity/Total Assets	52.19	55.86	50.66	45.38	66.47	74.05	72.6	63.4	63.85	60.16
Long-Term Debt/Equity (%)	20.43	3.36	1.21	24.41	8.03	4.82	0.2	7.3	4.2	9.51
Long-Term Debt/Capital (%)	13.58	3.04	1.29	18.72	7.63	4.87	0.23	7.66	4.59	9.91
Long-Term Debt/Total Assets (%)	10.66	2.12	0.73	12.92	5.83	3.88	0.17	5.37	3.16	6.86
Total Debt/Equity (%)	50.39	21.81	10.52	44.65	13.63	6.87	0.71	9.06	5.15	11.11
Total Debt/Capital (%)	33.51	19.74	11.19	34.24	12.95	6.94	0.81	9.51	5.64	11.58
Total Debt/Total Assets (%)	26.3	13.74	6.38	23.62	9.89	5.53	0.59	6.67	3.88	8.01
CFO/Total Liabilities	54.36	86.21	106.1	49.07	113.75	97.2	139.09	110.27	89.31	93.32
CFO/CapEx	3.83	3	3.66	1.43	2.69	1.14	1.21	1.73	1.03	1.3
Altman's Z-Score	2.73	3.37	6.71	5.55	8.8	7.84	11.27	7.23	7.2	3.54

Working Capital (USD)

API Chat

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	- -	6.44	6.92	7.88	10.98	9.29	9.85	10.82	10.34	10.7
Days Sales Outstanding	- -	56.68	52.71	46.33	33.23	39.28	37.07	33.74	35.29	34.1
Inventory Turnover	- -	7.53	7.38	11.42	27.9	18.31	17.96	17.12	20.35	24.52
Days Inventory Outstanding	- -	48.48	49.43	31.96	13.08	19.93	20.33	21.32	17.93	14.89
Accounts Payable Turnover	- -	4.67	3.51	3.62	11.5	10.19	10.89	11.58	10.84	10.67
Accounts Payable Turnover Days	- -	78.13	104.05	100.93	31.75	35.83	33.53	31.53	33.68	34.22
Cash Conversion Cycle	- -	27.03	-1.91	-22.64	14.56	23.38	23.87	23.52	19.54	14.77
Inventory to Cash Days	- -	8.2	3.29	14.37	20.15	19.35	16.75	12.42	17.35	19.21
Inventories	2	2	3	1	2	2	4	5	4	5
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	2	2	3	1	4	4	4	5	4	5

Enterprise Value (USD)

API Chat

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	- -	- -	144	234	301	206	292	301	311	- -
- Cash & Cash Equivalents	4	5	10	13	31	28	17	13	18	14
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	2	2
+ Total Debt	6	5	3	20	11	7	1	10	7	16
Enterprise Value	2	- -	137	240	281	184	276	299	302	4
Total Capital	19	26	31	57	86	94	86	109	122	138
Total Debt/Capital (%)	33.51	19.74	11.19	34.24	12.95	6.94	0.81	9.51	5.64	11.58
Total Debt / EV	3.02	63.94	0.02	0.08	0.04	0.04	- -	0.03	0.02	3.61
EV/Sales	0.07	- -	2.13	2.99	2.14	1.57	1.99	1.63	1.35	0.02
EV/EBITDA	0.35	- -	9.81	15.37	8.25	7.89	11.39	8.11	7.3	0.09
EV/EBIT	0.45	0.01	13.46	26.04	11.48	15.32	32.1	19.94	18.88	0.21
EV/Cash Flow to Firm	0.21	0.01	6.08	12.38	7.86	8.11	9.9	6.56	7.62	0.08
EV/Free Cash Flow to Firm	0.18	- -	4.78	7.32	5.76	4.34	5.44	4.17	3.9	0.05
Diluted Market Cap	- -	- -	151	246	314	212	301	317	327	- -
Diluted Enterprise Value	2	- -	144	253	295	190	285	314	318	4
EV per Share	0.06	- -	3.62	6.36	7.25	4.67	7.14	7.78	7.79	- -
TTM Sales	31	47	64	80	131	117	139	183	224	270
TTM EBITDA	6	17	14	16	34	23	24	37	41	49
TTM Operating Income	5	14	10	9	24	12	9	15	16	21
TTM Cash Flow to Firm	10	12	23	19	36	23	28	46	40	53
TTM Free Cash Flow to Firm	12	16	29	33	49	42	51	72	77	93

Multiples (USD)

API Chat

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	- -	- -	5.29	7.59	6.53	5.03	5.94	4.45	4.26	- -
EV/EBIT	0.45	0.01	13.46	26.04	11.48	15.32	32.1	19.94	18.88	0.21
Enterprise Value	2	- -	137	240	281	184	276	299	302	4
Low Price	- -	- -	1.68	3.25	2.44	4.96	3.56	5.9	6.21	5.93
EV/Sales	0.07	- -	2.13	2.99	2.14	1.57	1.99	1.63	1.35	0.02
EV/EBITDA	0.35	- -	9.81	15.37	8.25	7.89	11.39	8.11	7.3	0.09
Price/Earnings	- -	- -	15.14	27.43	9.54	22.59	46.97	29.39	27.59	- -
Price/Earnings Average	- -	- -	14.37	27.8	9.74	32.51	36.13	32.1	27.44	- -
Price/Earnings High	- -	- -	27.86	38.62	14.72	47.42	50.07	44.97	35.92	- -
Price/Earnings Low	- -	- -	6.71	14.38	3	21.46	22.12	22.09	21.36	- -
Price/Book Value	- -	- -	5.3	6.24	4.02	2.36	3.44	3.07	2.75	- -
Price/Book Value Average	- -	- -	5.03	6.32	4.11	3.4	2.65	3.35	2.73	- -
Price/Book Value High	- -	- -	9.74	8.79	6.2	4.95	3.67	4.69	3.58	- -
Price/Book Value Low	- -	- -	2.35	3.27	1.26	2.24	1.62	2.3	2.13	- -
Price/Tangible Book Value	- -	- -	4.42	5.35	3.68	2.17	3.01	3.6	3.12	- -
Price/Tangible Book Value Average	- -	- -	4.2	5.42	3.76	3.13	2.32	3.94	3.11	- -
Price/Tangible Book Value High	- -	- -	8.13	7.53	5.68	4.56	3.21	5.51	4.07	- -
Price/Tangible Book Value Low	- -	- -	1.96	2.81	1.16	2.07	1.42	2.71	2.42	- -
Price/Sales	- -	- -	2.23	2.91	2.29	1.76	2.1	1.65	1.39	- -
Price/Sales Average	- -	- -	2.12	2.95	2.34	2.53	1.62	1.8	1.38	- -
Price/Sales High	- -	- -	4.11	4.1	3.53	3.7	2.24	2.52	1.8	- -
Price/Sales Low	- -	- -	0.99	1.53	0.72	1.67	0.99	1.24	1.07	- -
Price/Cash Flow	- -	- -	6.44	12.25	8.56	9.16	10.53	6.66	7.95	- -
Price/Cash Flow Average	- -	- -	6.11	12.42	8.75	13.19	8.1	7.27	7.91	- -
Price/Cash Flow High	- -	- -	11.84	17.25	13.22	19.24	11.23	10.19	10.35	- -
Price/Cash Flow Low	- -	- -	2.85	6.42	2.69	8.71	4.96	5.01	6.16	- -
Price/Free Cash Flow Average	- -	- -	5.02	7.69	6.67	7.24	4.57	4.86	4.23	- -
Price/Free Cash Flow High	- -	- -	9.74	10.69	10.08	10.55	6.34	6.8	5.54	- -
Price/Free Cash Flow Low	- -	- -	2.34	3.98	2.05	4.78	2.8	3.34	3.3	- -
EV/Sales Average	0.07	- -	2.01	3.03	2.19	2.35	1.5	1.78	1.34	0.02
EV/Sales High	0.07	- -	4	4.18	3.38	3.51	2.13	2.5	1.77	0.02
EV/Sales Low	0.07	- -	0.88	1.6	0.57	1.49	0.87	1.22	1.03	0.02
EV/EBITDA Average	0.35	- -	9.29	15.57	8.44	11.78	8.61	8.86	7.26	0.09
EV/EBITDA High	0.35	- -	18.47	21.48	13.05	17.6	12.19	12.44	9.57	0.09
EV/EBITDA Low	0.35	- -	4.07	8.24	2.19	7.45	5.01	6.07	5.61	0.09
EV/EBIT Average	0.45	0.01	12.74	26.38	11.75	22.85	24.26	21.79	18.78	0.21
EV/EBIT High	0.45	0.01	25.33	36.39	18.17	34.16	34.35	30.59	24.75	0.21
EV/EBIT Low	0.45	0.01	5.58	13.97	3.05	14.47	14.12	14.94	14.5	0.21
Last Price	- -	- -	3.8	6.2	7.76	5.22	7.56	7.85	8.02	7.43
High Price	- -	- -	6.99	8.73	11.98	10.96	8.06	12.01	10.44	8.62
Enterprise Value Average	2	- -	130	243	287	275	209	326	300	4
Enterprise Value High	2	- -	258	335	444	411	295	458	396	4
Enterprise Value Low	2	- -	57	129	75	174	121	224	232	4

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	38	38	38	38	39	40	38	39	39	38
Diluted Weighted Avg Shares	38	38	40	40	41	41	40	40	41	- -
Basic Weighted Avg Shares	38	38	38	38	39	39	39	38	39	- -
Revenue per Share	0.83	1.24	1.7	2.13	3.39	2.96	3.59	4.77	5.79	- -
EBITDA per Share	0.16	0.44	0.37	0.41	0.88	0.59	0.63	0.96	1.07	- -
Operating Income per Share	0.13	0.37	0.27	0.24	0.63	0.3	0.22	0.39	0.41	- -
Basic EPS, GAAP	0.03	0.22	0.25	0.23	0.81	0.23	0.16	0.27	0.29	- -
Basic EPS from Cont Ops	0.03	0.22	0.25	0.23	0.81	0.23	0.16	0.27	0.29	- -
Diluted EPS, GAAP	0.03	0.22	0.24	0.21	0.78	0.22	0.16	0.25	0.28	- -
Diluted EPS from Cont Ops	0.03	0.22	0.24	0.21	0.78	0.22	0.16	0.25	0.28	- -
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	0.17	0.32	0.59	0.51	0.91	0.57	0.72	1.18	1.01	- -
Free Cash Flow per Basic Share	0.13	0.21	0.43	0.15	0.57	0.07	0.13	0.5	0.03	- -
Cash & Equivalents per Share	0.11	0.13	0.27	0.35	0.8	0.72	0.44	0.33	0.45	- -
Book Value per Share	0.34	0.56	0.72	0.99	1.93	2.21	2.2	2.56	2.92	- -
Tangible Book Value per Share	0.34	0.63	0.86	1.16	2.11	2.4	2.51	2.18	2.57	- -

Viemed Healthcare, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)